SLDB Q1 2026 Earnings WiderthanExpected Loss Amid Pipeline Progress Haemonetics Q1 2026 Earnings EPS Slightly Above Estimates Stock Gains 57 Tango Therapeutics Q1 2026 Earnings Slight EPS Miss as PreRevenue Biotech Focuses on Pipeline Progress NATL Q1 2026 Earnings EPS Misses Estimates by 269 Amid Operational Uncertainty XENE Q1 2026 Earnings Narrowed Loss Beats Estimates as Pipeline Progress Continues Core Scientific Inc CORZ Q1 2026 Earnings Massive EPS Miss Amidst Operational Challenges